Document Status

This document has been corrected

Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment

10.1038/s41392-023-01482-9

Published Online: 2023-05-22

Journal: Signal Transduction and Targeted Therapy•Publisher: Springer Science and Business Media LLC

Authors: Bo Feng•Haixia Su•Hong Liu•Jia Li•Leike Zhang•Tianqing Nie•Yi Zang•Yu Zhou•Yumin Zhang•Zhidong Jiang

This document has been corrected

Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment

10.1038/s41392-023-01482-9

Published Online: 2023-05-22

Journal: Signal Transduction and Targeted Therapy

Authors: Bo Feng•Haixia Su•Hong Liu•Jia Li•Leike Zhang•Tianqing Nie•Yi Zang•Yu Zhou•Yumin Zhang•Zhidong Jiang

NOW

2023-10-13•Correction

Correction: Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment

10.1038/s41392-023-01665-4

* information provided by CrossRef

2023-10-13•Correction

10.1038/s41392-023-01665-4

* information provided by CrossRef

2023-05-22•Published